Home

加入最愛

English

正子藥品

產品介紹 > 核醫藥品 > 正子藥品
F-18 FDG
2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) is actively up-taken by cells, phosphorylated by hexokinase and trapped by tissues with high glucose utilization, such as malignant tumors.

相關介紹

2-deoxy-2-[18F]fluoro--D-glucose ([18F]FDG) is actively up-taken by cells, phosphorylated by hexokinase and trapped by tissues with high glucose utilization, such as malignant tumors. Thus, [18F]FDG PET can be utilized for diagnosis, staging, and monitoring treatment of cancers, particularly in Hodgkin's disease, non-Hodgkin's lymphoma, colorectal cancer, breast cancer, melanoma, and lung cancer.
公司簡介產品介紹服務據點活動花絮相關網頁下載專區常見問答聯絡我們相關消息影音專區